700 reports

The drug claimed blockbuster status just one year after its launch.

  • Clinical Trial
  • Pharmaceutical
  • Therapy
  • Company
  • Market Size
  • Top Indications for CNS
  • CLINICAL TRIALS - THERAPY AREA PERSPECTIVE

PIPELINE PRODUCTS - REGIONAL BREAKDOWN - - - - - - - - - - - - - - - - - - - - - - - - - Stage US Europe Japan Canada Global Pre-Registration ## ## Filing Rejected/ Withdrawn ## ## Phase III ## ## ## ## Phase II ## ## ## Phase I ## ## ## ## Phase ## IND/ CTA Filed Precl

  • Clinical Trial
  • United States
  • Biogen Idec Inc.
  • Novartis AG
  • Sanofi S.A.

DEPRESSION IS ONE OF THE LEADING CAUSES OF DISABILITY IN THE UNITED STATES.

  • Clinical Trial
  • Injectable Delivery
  • Australasia
  • Australia
  • Oceania

TABLE ##.

  • Clinical Trial
  • Injectable Delivery
  • World
  • Forecast
  • Market Size
  • FREQUENTLY REPORTED AES DURING A PHASE III CLINICAL TRIAL COMPARING AZOPT, TRUSOPT, AND

HIGH PREVALENCE OF ANXIETY AND DEPRESSION IN PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA.

  • Clinical Trial
  • Injectable Delivery
  • Aerie Pharmaceuticals, Inc.
  • Allergan plc
  • Santen Pharmaceutical Co., Ltd.
  • Facial Injectables Market: Revenue in USD million, Hyaluronic Acid, Global, 2016-2024
  • BY APPLICATION

These fillers are safe and are well tolerated, with great results to fill the depression associated with scars.

  • Injectable Delivery
  • World
  • Allergan plc
  • Galderma S.A.
  • Nestlé S.A.

India ##.

  • Clinical Trial
  • World
  • Biogen Idec Inc.
  • Eisai Co., Ltd.
  • Roche Group
  • MARKET OUTLINE
  • MARKET CHALLENGES

Strength: ## Low; ## High Assessment B.

  • Analgesic
  • Clinical Trial
  • Drug Delivery
  • Injectable Delivery
  • Therapy

Food and Drug Administration (FDA) has approved SPRAVATO (esketamine) CIII nasal spray for use in conjunction with an oral antidepressant in adults with treatmentresistant depression (TRD).

  • Clinical Trial
  • Injectable Delivery
  • Forecast
  • Market Size
  • Baxter International Inc.
  • CLINICAL TRIAL INITIATE IN Q3 2018 BY GEOGRAPHY, GLOBAL
  • CRO Activity in 2018 (Q3)

PLoS One; ##(##): e##.

  • Clinical Trial
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.

THREATS OF SUBSTITUTES - LOW ##.

  • Injectable Delivery
  • World
  • Market Size
  • B. Braun Medical
  • Boston Scientific Corporation

THIS IS UTILIZED TO TREAT NEUROLOGICAL DISORDERS LIKE EPILEPSY AND DEPRESSION.

  • Injectable Delivery
  • Brazil
  • South America
  • B. Braun Melsungen AG
  • Medtronic, Inc.

OTHER COMMON AES INCLUDE DIZZINESS, DEPRESSION, SHORTNESS OF BREATH, BRADYCARDIA, HYPOTENSION, DIARRHEA, PRURITUS, AND RASH.

  • Clinical Trial
  • Injectable Delivery
  • Market Size
  • Bristol-Myers Squibb Company
  • Les Laboratoires Servier SAS

THIS IS UTILIZED TO TREAT NEUROLOGICAL DISORDERS LIKE EPILEPSY AND DEPRESSION.

  • Injectable Delivery
  • Latin America
  • Mexico
  • North America
  • Medtronic, Inc.

Depression and mood indicators in newly diagnosed glaucoma patients.

  • Clinical Trial
  • Injectable Delivery
  • Adverum Biotechnologies, Inc.
  • Alcon, Inc.
  • Allergan plc

IN ADDITION, ONE IN FIVE MEN WITH PCA HAS BEEN REPORTED TO EXPERIENCE DEPRESSION, WITH HALF OF THOSE MEN EXPERIENCING " SEVERE" DEPRESSION (HEIM AND OEI, 1993). ## Epidemiology ##. ## DISEASE BACKGROUND PCA IS A MALIGNANCY IN THE PROSTATE GLAND, WHICH IS LOCATED BELOW

  • Clinical Trial
  • Hospital
  • Injectable Delivery
  • Forecast
  • PROVENGE group
  • 12.7.4 MNM VIEW

It is also working on a complementary genomic depression test that does not require FDA approval.

  • Clinical Trial
  • Healthcare
  • World
  • Market Size
  • Cogstate Limited
  • 12.7.4 MNM VIEW

It is also working on a complementary genomic depression test that does not require FDA approval.

  • Clinical Trial
  • Healthcare
  • World
  • Market Size
  • Cogstate Limited
  • BIPOLAR DISORDER (MANIC DEPRESSION) THERAPEUTICS, G7 COUNTRIES, CLINICAL TRIALS BY PHASE, 2018*
  • TOP COMPANIES PARTICIPATING IN BIPOLAR DISORDER (MANIC DEPRESSION) THERAPEUTICS CLINICAL TRIALS

BIPOLAR DISORDER (MANIC DEPRESSION) THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* BIPOLAR DISORDER (MANIC DEPRESSION) THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* BIPOLAR DISORDER (MANIC DEPRESSION) THERAPEUTICS CLINICAL TRIALS,

  • Bipolar Disorder
  • Clinical Trial
  • Depression
  • Neurology
  • World

THIS IS UTILIZED TO TREAT NEUROLOGICAL DISORDERS LIKE EPILEPSY AND DEPRESSION.

  • Clinical Trial
  • Injectable Delivery
  • India
  • South Asia
  • Medtronic, Inc.

THIS IS UTILIZED TO TREAT NEUROLOGICAL DISORDERS LIKE EPILEPSY AND DEPRESSION.

  • Injectable Delivery
  • Italy
  • Southern Europe
  • B. Braun Melsungen AG
  • Medtronic, Inc.
  • 7. PEN NEEDLES MARKET ANALYSIS- BY TYPE

OBESITY IS ONE OF THE TOP FIVE RISK FACTORS FOR EARLY DEATH.

  • Clinical Trial
  • Injectable Delivery
  • World
  • Forecast
  • Market Size

THIS IS UTILIZED TO TREAT NEUROLOGICAL DISORDERS LIKE EPILEPSY AND DEPRESSION.

  • Injectable Delivery
  • East Asia
  • South Korea
  • Medtronic, Inc.
  • Stryker Corporation

THIS IS UTILIZED TO TREAT NEUROLOGICAL DISORDERS LIKE EPILEPSY AND DEPRESSION.

  • Injectable Delivery
  • Eastern Europe
  • Russia
  • B. Braun Melsungen AG
  • Medtronic, Inc.

THIS IS UTILIZED TO TREAT NEUROLOGICAL DISORDERS LIKE EPILEPSY AND DEPRESSION.

  • Injectable Delivery
  • Southern Europe
  • Spain
  • B. Braun Melsungen AG
  • Medtronic, Inc.

Food and Drug Administration (FDA) has approved SPRAVATO (esketamine) CIII nasal spray for use in conjunction with an oral antidepressant in adults with treatment-resistant depression (TRD).

  • Clinical Trial
  • Injectable Delivery
  • North America
  • Forecast
  • Market Size

The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study.

  • Clinical Trial
  • Injectable Delivery
  • Market Size
  • AbbVie Inc.
  • Janssen Biotech, Inc.

One unit refers to one CDU.

  • Injectable Delivery
  • Canada
  • Getinge Group
  • LivaNova PLC
  • Medtronic, Inc.

According to Office of National Statistics, one in every four UK citizens are affected with depression.

  • Clinical Trial
  • Injectable Delivery
  • World
  • Forecast
  • Allergan plc
  • TREATMENT RESISTANT DEPRESSION THERAPEUTICS, G7 COUNTRIES, CLINICAL TRIALS BY TRIAL STATUS, 2018*
  • TREATMENT RESISTANT DEPRESSION THERAPEUTICS, E7 COUNTRIES, CLINICAL TRIALS BY PHASE, 2018*

TREATMENT RESISTANT DEPRESSION THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* CLINICAL TRIALS BY PHASE IN E## COUNTRIES TREATMENT RESISTANT DEPRESSION THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* TREATMENT RESISTANT DEPRESSION THERAPEUTICS, E## CO

  • Clinical Trial
  • Depression
  • Therapy
  • World
  • Product Initiative